Biogen (BIIB, $225.34) was one of the top gainers for the month, rising to $225.34 per share. A.I.dvisor analyzed 58 stocks in the Pharmaceuticals: Major Industry for the month ending May 13, 2024 and discovered that of them () exhibited an Uptrend while of them () exhibited a Downtrend.